NCT00633386View on ClinicalTrials.gov

Effect of Celecoxib Versus Placebo Before and After Knee Surgery on the Overall Use of Analgesics After Surgery

PHASE4CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

February 28, 2003

Study Completion Date

August 31, 2003

Conditions
Arthroscopy
Interventions
DRUG

Celecoxib

400 mg oral capsule as a single dose 1 hour prior to surgery and 200 mg oral capsule as a single dose as needed post-surgery

OTHER

Placebo

Matched placebo

Trial Locations (9)

21218

Pfizer Investigational Site, Baltimore

29204

Pfizer Investigational Site, Columbia

33713

Pfizer Investigational Site, St. Petersburg

37601

Pfizer Investigational Site, Johnson City

65804

Pfizer Investigational Site, Springfield

78229

Pfizer Investigational Site, San Antonio

85023

Pfizer Investigational Site, Phoenix

01199

Pfizer Investigational Site, Springfield

22908-0159

Pfizer Investigational Site, Charlottesville

All Listed Sponsors
lead

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

INDUSTRY

NCT00633386 - Effect of Celecoxib Versus Placebo Before and After Knee Surgery on the Overall Use of Analgesics After Surgery | Biotech Hunter | Biotech Hunter